Dr. Emily Slotkin, MD
Claim this profileMemorial Sloan Kettering Cancer Center
Studies Desmoplastic Small Round Cell Tumor
Studies Soft Tissue Sarcoma
14 reported clinical trials
22 drugs studied
Area of expertise
1Desmoplastic Small Round Cell Tumor
Stage III
Stage IV
2Soft Tissue Sarcoma
Stage IV
Stage III
Affiliated Hospitals
Clinical Trials Emily Slotkin, MD is currently running
Health Information Collection
for Desmoplastic Small Round Cell Tumor
This study is a patient registry of people with Desmoplastic Small Round Cell Tumor (DSRCT). A patient registry is a collection of health information about a group of people, and it is usually focused on a specific diagnosis or disease. The purpose of this registry is to create a database- a collection of information-or better understanding DSRCT. Researchers will use the information from this database to learn more about DSRCT and for current and future research on DSRCT.
Recruiting1 award N/A2 criteria
Multiple Drug Therapies
for Cancer in Children and Young Adults
This trial tests new cancer drugs to see if they help patients and how long the benefits last. It focuses on different types of cancer and adds new studies as new drugs are developed.
Recruiting1 award Phase 2
More about Emily Slotkin, MD
Clinical Trial Related4 years of experience running clinical trials · Led 14 trials as a Principal Investigator · 5 Active Clinical TrialsTreatments Emily Slotkin, MD has experience with
- Irinotecan
- Temozolomide
- Gemcitabine
- Ramucirumab
- Docetaxel
- Cyclophosphamide
Breakdown of trials Emily Slotkin, MD has run
Desmoplastic Small Round Cell Tumor
Soft Tissue Sarcoma
Ewing Sarcoma
Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Emily Slotkin, MD specialize in?
Emily Slotkin, MD focuses on Desmoplastic Small Round Cell Tumor and Soft Tissue Sarcoma. In particular, much of their work with Desmoplastic Small Round Cell Tumor has involved Stage III patients, or patients who are Stage IV.
Is Emily Slotkin, MD currently recruiting for clinical trials?
Yes, Emily Slotkin, MD is currently recruiting for 5 clinical trials in New York New York. If you're interested in participating, you should apply.
Are there any treatments that Emily Slotkin, MD has studied deeply?
Yes, Emily Slotkin, MD has studied treatments such as Irinotecan, Temozolomide, Gemcitabine.
What is the best way to schedule an appointment with Emily Slotkin, MD?
Apply for one of the trials that Emily Slotkin, MD is conducting.
What is the office address of Emily Slotkin, MD?
The office of Emily Slotkin, MD is located at: Memorial Sloan Kettering Cancer Center, New York, New York 10065 United States. This is the address for their practice at the Memorial Sloan Kettering Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.